Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Application - 2020

Manufacturers Notice of Application - 2020

Purisys, LLC (July 9, 2020)

Cambrex Charles City (June 17, 2020)

SpecGx LLC (Correction) (June 11, 2020)

Honeoye Manufacturing (June 9, 2020)

Sigma Aldrich Research Biochemicals, Inc. (June 5, 2020)

Chemtos, LLC (June 5, 2020)

Nalas Engineering Services, Inc. (June 5, 2020)

Noramco, Inc. (May 22, 2020)

SpecGx LLC (May 18, 2020)

Purisys, LLC (May 7, 2020)

Alcami Wisconsin Corporation (May 7, 2020)

Research Triangle Institute (May 5, 2020)

Patheon API Manufacturing, Inc. (May 5, 2020)

Absolute Standards, Inc. (May 5, 2020)

Cedarburg Pharmaceuticals (April 21, 2020)

Groff NA Hemplex LLC (April 20, 2020)

AMRI Rensselaer, Inc. (April 20, 2020)

Absolute Standards, Inc. (April 20, 2020)

Denco, LLC (April 16, 2020)

American Radiolabeled Chem (April 7, 2020)

Benuvia Therapeutics Inc. (April 7, 2020)

Pisgah Laboratories, Inc. (March 24, 2020)

Cargill, Inc. (March 24, 2020)

Johnson Matthey Inc. (March 24, 2020)

Siegfried USA, LLC (March 19, 2020)

Navinta LLC (March 19, 2020)

Scottsdale Research Institute (February 24, 2020)

Synthcon, LLC (February 24, 2020)

Stepan Company (February 24, 2020)

Irvine Labs, Inc. (February 24, 2020)

Patheon Pharmaceuticals, Inc. (February 24, 2020)

Chemtos, LLC (February 24, 2020)

Noramco Inc. (February 3, 2020)

Spocannabis LLC (February 3, 2020)

IsoSciences, LLC (February 3, 2020)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility